Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkers
Title:
Phase II trial of everolimus in patients with refractory metastatic adenocarcinoma of the esophagus, gastroesophageal junction and stomach: possible role for predictive biomarkers
Author:
Wainberg, Zev A. Soares, Heloisa P. Patel, Ravi DiCarlo, Brian Park, David J. Liem, Andre Wang, He-jing Yonemoto, Lisa Martinez, Diego Laux, Isett Brennan, Meghan Hecht, J. Randolph